Tell me in October when Q1 report comes out about how long cash on hand will last. Because of Book to bill delay you can already figure it out if you want to. Everyone is impressed with current cash. Few understand that it is realy not very much compared to what they are doing and NdPrO price down
from 1100 to 477, -67% which directly changes cash coming in. Do not forget if they had not diluted your stock to raise 213Min in 2023 it would only be $800M So they need all that cash on hand plus more. Get ready for more stock dilution. Probably early 2024 JMO but it will probably be 4 ~8 times the number of shares this time around. Will need more money, and SP will be lower.
https://wcsecure.weblink.com.au/pdf/LYC/02640930.pdf
https://wcsecure.weblink.com.au/pdf/LYC/02691935.pdf
Cash coming in is Price times volume. Volume is up see page 5 of Q4 link above. but only a little. NdPrO is down from 1100 to 477 -63 % What do you think cash in will be in Q1.
- Forums
- ASX - By Stock
- Technical
LYC
lynas rare earths limited
Add to My Watchlist
3.48%
!
$8.88

Tell me in October when Q1 report comes out about how long cash...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$8.88 |
Change
-0.320(3.48%) |
Mkt cap ! $8.306B |
Open | High | Low | Value | Volume |
$9.44 | $9.44 | $8.86 | $61.13M | 6.800M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
7 | 225 | $8.88 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$8.91 | 24100 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 2 | 8.880 |
1 | 80 | 8.850 |
1 | 508 | 8.830 |
1 | 675 | 8.820 |
6 | 3145 | 8.800 |
Price($) | Vol. | No. |
---|---|---|
8.930 | 200 | 1 |
8.950 | 200 | 1 |
8.960 | 650 | 1 |
8.990 | 164 | 1 |
9.020 | 1100 | 1 |
Last trade - 16.11pm 27/06/2025 (20 minute delay) ? |
Featured News
LYC (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online